- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07922304
Aroma Inhalation and Exam Stress: Role of Emotional Intelligence and Stress Biomarkers
Effect of Aroma Inhalations (Thyme and Juniper) on Exam Stress and Apelin and Cerebral (BDNF) Stress Response (GRP78) According to Emotional Intelligence Levels and Stress Management Skills
This study is an interventional investigation aiming to evaluate the physiological effects of thyme (Thymus vulgaris) and juniper (Juniperus communis) essential oil aroma inhalation on examination stress in medical students. The research assesses participants' emotional intelligence and exam anxiety levels, and analyzes changes in salivary apelin, BDNF, and GRP78 levels using the ELISA method before and after the aromatherapy intervention.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Study Purpose: This study aims to investigate the effects of aroma inhalations (thyme and juniper) on exam stress, adipokines (apelin), neurotrophic factors (BDNF), and endoplasmic reticulum stress responses (GRP78) based on emotional intelligence and exam anxiety levels in medical students. Methods: The study is a three-arm, randomized, controlled interventional investigation conducted on healthy volunteer medical students. Saliva samples are collected before inhalation and immediately after the 15-minute intervention. The ELISA technique is utilized to determine salivary apelin, BDNF, and GRP78 levels.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Altindag
-
Ankara, Altindag, Turquie (Türkiye), 06050
- Ankara Medipol University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
Being willing to participate in the research, being a medical student, not having a cardiovascular disease, not having any allergies to odors, not being pregnant, not having any respiratory system diseases (such as asthma, COPD, etc.), not having any condition that prevents smelling, not using any medication that affects heart rate and blood pressure, and not having any psychiatric illness.
Exclusion Criteria:
The communication barrier, incomplete filling of forms, menstruation in girls, allergy to the scents of thyme and juniper oil, and the occurrence of any side effects during the application.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Non randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Juniper Aromatherapy Group
Participants inhale juniper essential oil for 40 minutes during the exam. Physiological and hormonal measurements are taken before and after inhalation. |
Participants inhale juniper essential oil (2 drops) via a diffuser or inhaler for approximately 40 minutes during the exam session. This inhalation is intended to assess effects on anxiety-related physiological and hormonal parameters. |
|
Expérimental: Thyme Aromatherapy Group
Participants inhale thyme essential oil for 40 minutes during the exam. Physiological and hormonal measurements are taken before and after inhalation. |
Participants inhale thyme essential oil (2 drops) via a diffuser or inhaler for approximately 40 minutes during the exam session. This inhalation is intended to assess effects on anxiety-related physiological and hormonal parameters. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Salivary Apelin Levels
Délai: Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Salivary apelin levels will be measured to evaluate the metabolic and neuroendocrine response to aroma inhalation. |
Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
|
Change in Salivary BDNF Levels
Délai: Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Salivary BDNF levels will be measured as a neurotrophic and physiological stress indicator. |
Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
|
Change in Salivary GRP78 Levels
Délai: Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Salivary GRP78 levels will be measured to monitor cellular endoplasmic reticulum stress responses. |
Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- AROMA-MED-2025-02
- E-81477236-604.01.01-3006 (Autre identifiant: Ethics Committee Approval Number, Ankara Medipol University Faculty of Medicine, Turkey)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
The individual participant data (IPD) will not be shared due to ethical considerations and institutional restrictions.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .